Royal Bank of Canada’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329M | Buy |
|
|||||
|
2025
Q1 | $294M | Buy |
|
|||||
|
2024
Q4 | $242M | Sell |
|
|||||
|
2024
Q3 | $293M | Buy |
|
|||||
|
2024
Q2 | $271M | Sell |
|
|||||
|
2024
Q1 | $349M | Sell |
|
|||||
|
2023
Q4 | $307M | Buy |
|
|||||
|
2023
Q3 | $293M | Buy |
|
|||||
|
2023
Q2 | $274M | Buy |
|
|||||
|
2023
Q1 | $77M | Buy |
|
|||||
|
2022
Q4 | $64M | Buy |
|
|||||
|
2022
Q3 | $51.3M | Buy |
|
|||||
|
2022
Q2 | $89.5M | Sell |
|
|||||
|
2022
Q1 | $90.1M | Sell |
|
|||||
|
2021
Q4 | $91.7M | Sell |
|
|||||
|
2021
Q3 | $84.4M | Buy |
|
|||||
|
2021
Q2 | $81.7M | Sell |
|
|||||
|
2021
Q1 | $348M | Sell |
|
|||||
|
2020
Q4 | $541M | Sell |
|
|||||
|
2020
Q3 | $586M | Sell |
|
|||||
|
2020
Q2 | $684M | Sell |
|
|||||
|
2020
Q1 | $652M | Buy |
|
|||||
|
2019
Q4 | $454M | Sell |
|
|||||
|
2019
Q3 | $423M | Sell |
|
|||||
|
2019
Q2 | $445M | Sell |
|
|||||
|
2019
Q1 | $471M | Sell |
|
|||||
|
2018
Q4 | $646M | Sell |
|
|||||
|
2018
Q3 | $803M | Sell |
|
|||||
|
2018
Q2 | $845M | Sell |
|
|||||
|
2018
Q1 | $832M | Sell |
|
|||||
|
2017
Q4 | $906M | Buy |
|
|||||
|
2017
Q3 | $351M | Sell |
|
|||||
|
2017
Q2 | $390M | Buy |
|
|||||
|
2017
Q1 | $367M | Buy |
|
|||||
|
2016
Q4 | $324M | Sell |
|
|||||
|
2016
Q3 | $369M | Sell |
|
|||||
|
2016
Q2 | $396M | Buy |
|
|||||
|
2016
Q1 | $363M | Sell |
|
|||||
|
2015
Q4 | $473M | Buy |
|
|||||
|
2015
Q3 | $418M | Sell |
|
|||||
|
2015
Q2 | $485M | Sell |
|
|||||
|
2015
Q1 | $553M | Sell |
|
|||||
|
2014
Q4 | $587M | Buy |
|
|||||
|
2014
Q3 | $621M | Sell |
|
|||||
|
2014
Q2 | $749M | Buy |
|
|||||
|
2014
Q1 | $748M | Sell |
|
|||||
|
2013
Q4 | $958M | Sell |
|
|||||
|
2013
Q3 | $904M | Sell |
|
|||||
|
2013
Q2 | $906M | Buy |
|